Skip to main content
. Author manuscript; available in PMC: 2022 Feb 2.
Published in final edited form as: J Cogn Psychother. 2011;25(1):82–96. doi: 10.1891/0889-8391.25.1.82

TABLE 1.

Baseline Demographic and Smoking Characteristics

Variable Major
Depressive
Disorder
(N = 194)
Mean (SD)/
%Within
Group (freq)
Anxiety
Disordersa
(N = 53)
Mean (SD)/
% Within
Group (freq)
Alcohol
Abuseb
(N = 92)
Mean (SD)/
% Within
Group (freq)
Comorbid
Anxietya and
Depressive
Disorders
(N = 192)
Mean (SD)/
% Within
Group (freq)
Comorbid
Anxietya
Depressive
Disorders
and Alcohol
Abuseb
(N = 63)
Mean (SD)/
% Within
Group (freq)
No Psychiatric
Disorder
(N = (831)
Mean (SD)/
% Within
Group (freq)
Total
(N = 1,425)
Mean (SD
)/% (freq)
Age (years)* 54.5 (11.3)1 50.8 (12.0)1,2 53.4 (11.0)1,2 51.3 (11.5)2 51.0 (11.1)2 54.1 (10.7)1 53.4(11.0)
Gender*
 Male 51.0 (99) 28.3 (15) 70.7 (65) 32.3 (62) 54.0 (34) 53.0 (443) 50.4 (718)
 Female 49.0 (95)1 71.7 (38)2 29.3 (27)3 67.7 (130)2 46.0 (29)1 46.7 (388)1 49.6 (707)
Race/Ethnicity
 African American, non-Hispanic 11.3 (22) 7.6 (4) 5.4 (5) 12.5 (24) 9.5 (6) 9.6 (80) 10.1 (141)
 White, non-Hispanic 80.4 (156) 81.1 (43) 82.5 (75) 78.7 (151) 76.2 (48) 79.9 (664) 81.2 (1137)
 Hispanic 4.1 (8) 5.7 (3) 3.3 (3) 4.7 (9) 6.4 (4) 4.1 (34) 4.4 (61)
 Other 1.6 (3) 3.8 (2) 2.2 (2) 0.5 (1) 0 (0) 2.7 (22) 2.1 (30)
 Unknownc 2.6 (5) 1.9 (1) 7.6 (7) 3.7 (7) 7.9 (5) 3.7 (31) 2.3 (32)
Referring Clinic
 Breast 13.9 (27) 22.6 (12) 11.0 (10) 17.7 (34) 9.5 (6) 12.9 (107) 13.4 (196)
 Dermatology 2.1 (4) 3.8 (2) 3.3 (3) 2.6 (5) 9.5 (6) 5.1 (42) 4.4 (62)
 Gastrointestinal 7.2 (14) 3.8 (2) 5.4 (5) 5.2 (10) 3.2 (2) 6.6 (55) 6.0 (85)
 Genitourinary 9.8 (19) 9.4 (5) 14.1 (13) 13.0 (25) 7.9 (5) 13.0 (108) 12.3 (175)
 Head and neck 20.1 (39) 17.0 (9) 22.8 (21) 17.2 (33) 30.2 (19) 18.7 (155) 19.4 (276)
 Hematology 10.3 (20) 7.6 (4) 4.4 (4) 9.4 (18) 9.5 (6) 9.6 (80) 9.3 (132)
 Thoracic 17.0 (33) 13.2 (7) 14.1 (13) 15.1 (29) 15.9 (10) 13.0 (108) 14.1 (200)
 Cancer prevention 8.8 (17) 11.3 (6) 18.5 (17) 5.7 (11) 14.3 (9) 11.9 (99) 9.6 (137)
 Otherd 10.8 (21) 11.3 (6) 6.5 (6) 14.1 (27) 0 (0) 9.3 (77) 11.2 (159)
Smoking rate (cigarettes/day) 20.8 (12.6) 18.6 (15.0) 21.6 (12.7) 20.4 (12.1) 20.7 (14.0) 18.8 (11.7) 19.0 (12.5)
FTNDe score* 5.4, (2.0)1 5.2 (2.5)1,2 5.0 (2.3)1,2 5.3 (2.1)1 5.1 (2.7)1,2 4.7 (2.2)2 4.9 (2.2)
Smoking Cessation Medication
 No medication 10.8 (21) 9.4 (5) 10.9 (10) 13.0 (25) 11.1 (7) 13.2 (110) 12.5 (178)
 Bupropion 5.7 (11) 5.7 (3) 1.1 (1) 4.2 (8) 3.2 (2) 4.0 (33) 4.1 (585)
 Varenicline 41.2 (80) 39.6 (21) 44.6 (41) 33.9 (65) 39.7 (25) 42.5 (353) 41.1 (585)
 Nicotine replacement 14.4 (28) 13.2 (7) 15.2 (14) 14.1 (27) 17.5 (11) 16.6 (138) 15.8 (225)
 Combination treatment 27.8 (54) 32.1 (17) 28.3 (26) 34.9 (67) 28.6 (18) 23.7 (197) 26.6 (379)
Counseling Sessions 8.4 (6.3) 9.2 (6.9) 8.3 (5.1) 8.3 (6.8) 7.6 (6.3) 8.2 (5.6) 8.2 (6.0)

Note.

a

Includes panic and other anxiety disorders.

b

Probable alcohol abuse/dependence.

c

Patients had the option of not answering the question about race.

d

Referring clinics with less than 2% of total.

e

FTND = Fagerstrom Test for Nicotine Dependence. Means in the same row that do not share numeric subscripts differ at p < .05 on Tukey’s Studentized Range Test for age and FTND and chi–square for sex.

*

p < .01.